Advertisements



ADMA Biologics: FDA establishes target action date of Dec. 18 for Bivigam PAS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

ADMA Biologics receives PDUFA date for BIVIGAM regulatory submission

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 26th, 2018

FDA PDUFA Date for ADMA Biologics Bivigam is December 18, 2018

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 18th, 2018

ADMA Biologics: FDA approves PAS for BIVIGAM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2019

ADMA Biologics price target raised to $13 from $10 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

FDA PDUFA Date for ADMA Biologics RI-002 is April 2, 2019

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2019

ADMA Biologics stock price target raised to $16 from $14 at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 2nd, 2019

FDA Confirms September Action Date for Teva"s Migraine Drug

Teva (TEVA) confirms that FDA has extended the goal date of the Biologics License Application (BLA) for fremanezumab to September from mid-June. Teva Pharmaceutical Industries Ltd. TEVA confirmed that FDA has extended t.....»»

Category: smallbizSource: nytMay 24th, 2018

ADMA Biologics price target lowered to $7.50 from $10 at Ladenburg

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

ADMA Biologics price target raised to $12 from $10 at Maxim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 26th, 2018

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?.....»»

Category: topSource: seekingalphaAug 31st, 2018

ADMA Biologics receives PDUFA date of April 2, 2019 for RI-002

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

ADMA Biologics says hasn"t received FDA communication regarding BIVIGAM"s PAS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2018

ADMA Biologics provides regulatory update on Bivigam PAS submission

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2018

Here"s Why ADMA Biologics Is Getting Hammered Today

The company's attempt to relaunch Bivigam hit a wall -- again......»»

Category: topSource: foxnewsDec 20th, 2018

ADMA Biologics submits response to FDA for Bivigam CRL

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2019

ADMA Biologics: Under-The-Radar Biotech With Huge Potential Upside

ADMA Biologics: Under-The-Radar Biotech With Huge Potential Upside.....»»

Category: topSource: seekingalpha12 hr. 6 min. ago

Adma Biologics Inc (ADMA) President and CEO Adam S Grossman Bought $120,000 of Shares

Related Stocks: ADMA,.....»»

Category: dealsSource: nytMay 21st, 2019

ADMA Biologics 11.25M share Secondary priced at $4.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2019

ADMA Biologics files to sell $45M of common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Lipocine announces TLANDO NDA PDUFA action date of November 9

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019